位置:首页 > 蛋白库 > GIPC1_HUMAN
GIPC1_HUMAN
ID   GIPC1_HUMAN             Reviewed;         333 AA.
AC   O14908; A8K4I3; A8MZG3; Q9BTC9;
DT   18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1999, sequence version 2.
DT   03-AUG-2022, entry version 190.
DE   RecName: Full=PDZ domain-containing protein GIPC1;
DE   AltName: Full=GAIP C-terminus-interacting protein;
DE   AltName: Full=RGS-GAIP-interacting protein;
DE   AltName: Full=RGS19-interacting protein 1;
DE   AltName: Full=Synectin;
DE   AltName: Full=Tax interaction protein 2;
DE            Short=TIP-2;
GN   Name=GIPC1; Synonyms=C19orf3, GIPC, RGS19IP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH RGS19, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Pituitary;
RX   PubMed=9770488; DOI=10.1073/pnas.95.21.12340;
RA   De Vries L., Lou X., Zhao G., Zheng B., Farquhar M.G.;
RT   "GIPC, a PDZ domain containing protein, interacts specifically with the C-
RT   terminus of RGS-GAIP.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:12340-12345(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 78-333 (ISOFORM 1/2), AND INTERACTION WITH
RP   HTLV-I TAX.
RX   PubMed=9482110; DOI=10.1038/sj.onc.1201567;
RA   Rousset R., Fabre S., Desbois C., Bantignies F., Jalinot P.;
RT   "The C-terminus of the HTLV-1 Tax oncoprotein mediates interaction with the
RT   PDZ domain of cellular proteins.";
RL   Oncogene 16:643-654(1998).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-225 AND SER-232, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-68; SER-222; SER-225;
RP   SER-232; THR-242 AND SER-247, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-232, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   INVOLVEMENT IN OPDM2, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=32413282; DOI=10.1016/j.ajhg.2020.04.011;
RA   Deng J., Yu J., Li P., Luan X., Cao L., Zhao J., Yu M., Zhang W., Lv H.,
RA   Xie Z., Meng L., Zheng Y., Zhao Y., Gang Q., Wang Q., Liu J., Zhu M.,
RA   Guo X., Su Y., Liang Y., Liang F., Hayashi T., Maeda M.H., Sato T., Ura S.,
RA   Oya Y., Ogasawara M., Iida A., Nishino I., Zhou C., Yan C., Yuan Y.,
RA   Hong D., Wang Z.;
RT   "Expansion of GGC Repeat in GIPC1 Is Associated with Oculopharyngodistal
RT   Myopathy.";
RL   Am. J. Hum. Genet. 106:793-804(2020).
CC   -!- FUNCTION: May be involved in G protein-linked signaling.
CC   -!- SUBUNIT: Interacts with GLUT1 (C-terminus), ACTN1, KIF1B, MYO6,
CC       PLEKHG5, SDC4/syndecan-4 and SEMA4C/semaphorin-4C (By similarity).
CC       Interacts with RGS19 C-terminus. Interacts with HTLV-I Tax through the
CC       PDZ domain. {ECO:0000250, ECO:0000269|PubMed:9482110,
CC       ECO:0000269|PubMed:9770488}.
CC   -!- INTERACTION:
CC       O14908; Q9HB19: PLEKHA2; NbExp=3; IntAct=EBI-373132, EBI-4401947;
CC       O14908; Q03167: TGFBR3; NbExp=3; IntAct=EBI-373132, EBI-2852679;
CC       O14908; P17643: TYRP1; NbExp=3; IntAct=EBI-373132, EBI-7900408;
CC       O14908-2; Q8NC06-3: ACBD4; NbExp=3; IntAct=EBI-25913156, EBI-12811089;
CC       O14908-2; Q9NP61: ARFGAP3; NbExp=3; IntAct=EBI-25913156, EBI-2875816;
CC       O14908-2; Q8TBE0: BAHD1; NbExp=3; IntAct=EBI-25913156, EBI-742750;
CC       O14908-2; P20849: COL9A1; NbExp=3; IntAct=EBI-25913156, EBI-2528238;
CC       O14908-2; Q6NZ36-4: FAAP20; NbExp=3; IntAct=EBI-25913156, EBI-12013806;
CC       O14908-2; Q96GL9: FAM163A; NbExp=3; IntAct=EBI-25913156, EBI-11793142;
CC       O14908-2; Q06547-2: GABPB1; NbExp=3; IntAct=EBI-25913156, EBI-618189;
CC       O14908-2; Q7LGA3-3: HS2ST1; NbExp=3; IntAct=EBI-25913156, EBI-25887463;
CC       O14908-2; Q14005-2: IL16; NbExp=3; IntAct=EBI-25913156, EBI-17178971;
CC       O14908-2; P57682: KLF3; NbExp=3; IntAct=EBI-25913156, EBI-8472267;
CC       O14908-2; Q9Y2M5: KLHL20; NbExp=3; IntAct=EBI-25913156, EBI-714379;
CC       O14908-2; Q15759: MAPK11; NbExp=3; IntAct=EBI-25913156, EBI-298304;
CC       O14908-2; Q9Y266: NUDC; NbExp=3; IntAct=EBI-25913156, EBI-357298;
CC       O14908-2; Q6P4D5-2: PABIR3; NbExp=3; IntAct=EBI-25913156, EBI-9091052;
CC       O14908-2; Q8WZ73-3: RFFL; NbExp=3; IntAct=EBI-25913156, EBI-25839575;
CC       O14908-2; Q969K3: RNF34; NbExp=3; IntAct=EBI-25913156, EBI-2340642;
CC       O14908-2; P48443: RXRG; NbExp=3; IntAct=EBI-25913156, EBI-712405;
CC       O14908-2; Q8N488: RYBP; NbExp=3; IntAct=EBI-25913156, EBI-752324;
CC       O14908-2; Q9BY12-3: SCAPER; NbExp=3; IntAct=EBI-25913156, EBI-25837959;
CC       O14908-2; Q86SQ7-2: SDCCAG8; NbExp=3; IntAct=EBI-25913156, EBI-10696955;
CC       O14908-2; Q2NKQ1-4: SGSM1; NbExp=3; IntAct=EBI-25913156, EBI-10182463;
CC       O14908-2; O75558: STX11; NbExp=3; IntAct=EBI-25913156, EBI-714135;
CC       O14908-2; O15273: TCAP; NbExp=3; IntAct=EBI-25913156, EBI-954089;
CC       O14908-2; O60830: TIMM17B; NbExp=3; IntAct=EBI-25913156, EBI-2372529;
CC       O14908-2; Q5VYS8-5: TUT7; NbExp=3; IntAct=EBI-25913156, EBI-9088812;
CC       O14908-2; Q9H9P5-5: UNKL; NbExp=3; IntAct=EBI-25913156, EBI-12817837;
CC       O14908-2; Q96EF9: ZHX1-C8orf76; NbExp=3; IntAct=EBI-25913156, EBI-25830993;
CC       O14908-2; Q8WUU4: ZNF296; NbExp=3; IntAct=EBI-25913156, EBI-8834821;
CC       O14908-2; Q8N0Y2-2: ZNF444; NbExp=3; IntAct=EBI-25913156, EBI-12010736;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:32413282,
CC       ECO:0000269|PubMed:9770488}. Membrane {ECO:0000269|PubMed:9770488};
CC       Peripheral membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O14908-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O14908-2; Sequence=VSP_044296;
CC   -!- TISSUE SPECIFICITY: Widely expressed (PubMed:9770488). Expressed in
CC       skeletal muscle (at protein level) (PubMed:32413282).
CC       {ECO:0000269|PubMed:32413282, ECO:0000269|PubMed:9770488}.
CC   -!- DISEASE: Oculopharyngodistal myopathy 2 (OPDM2) [MIM:618940]: A form of
CC       oculopharyngodistal myopathy, a muscle disorder characterized by
CC       progressive ptosis, external ophthalmoplegia, and weakness of the
CC       masseter, facial, pharyngeal, and distal limb muscles. The
CC       myopathological features are presence of rimmed vacuoles in the muscle
CC       fibers and myopathic changes of differing severity. OPDM2 inheritance
CC       pattern is autosomal dominant. {ECO:0000269|PubMed:32413282}. Note=The
CC       disease may be caused by variants affecting the gene represented in
CC       this entry. GGC repeat expansions in the 5'-UTR ranging from 73 to 164
CC       were reported in patients, compared with a normal range from 12 to 32
CC       in unaffected individuals. Patient skeletal muscle showed similar
CC       protein levels to those of unaffected individuals.
CC       {ECO:0000269|PubMed:32413282}.
CC   -!- SIMILARITY: Belongs to the GIPC family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF089816; AAC67548.1; -; mRNA.
DR   EMBL; AK290948; BAF83637.1; -; mRNA.
DR   EMBL; AC008569; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC012318; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471106; EAW84423.1; -; Genomic_DNA.
DR   EMBL; CH471106; EAW84425.1; -; Genomic_DNA.
DR   EMBL; BC000410; AAH00410.1; -; mRNA.
DR   EMBL; BC004226; AAH04226.2; -; mRNA.
DR   EMBL; BC012810; AAH12810.1; -; mRNA.
DR   EMBL; BC016169; AAH16169.1; -; mRNA.
DR   EMBL; AF028824; AAB84249.1; -; mRNA.
DR   CCDS; CCDS12310.1; -. [O14908-1]
DR   CCDS; CCDS12311.1; -. [O14908-2]
DR   RefSeq; NP_005707.1; NM_005716.3. [O14908-1]
DR   RefSeq; NP_974197.1; NM_202468.2. [O14908-1]
DR   RefSeq; NP_974198.1; NM_202469.2. [O14908-2]
DR   RefSeq; NP_974199.1; NM_202470.2. [O14908-1]
DR   RefSeq; NP_974223.1; NM_202494.2. [O14908-2]
DR   RefSeq; XP_016881636.1; XM_017026147.1. [O14908-1]
DR   RefSeq; XP_016881637.1; XM_017026148.1. [O14908-2]
DR   AlphaFoldDB; O14908; -.
DR   SMR; O14908; -.
DR   BioGRID; 115978; 97.
DR   CORUM; O14908; -.
DR   DIP; DIP-31142N; -.
DR   IntAct; O14908; 55.
DR   MINT; O14908; -.
DR   STRING; 9606.ENSP00000376753; -.
DR   iPTMnet; O14908; -.
DR   PhosphoSitePlus; O14908; -.
DR   BioMuta; GIPC1; -.
DR   EPD; O14908; -.
DR   jPOST; O14908; -.
DR   MassIVE; O14908; -.
DR   MaxQB; O14908; -.
DR   PaxDb; O14908; -.
DR   PeptideAtlas; O14908; -.
DR   PRIDE; O14908; -.
DR   ProteomicsDB; 1863; -.
DR   ProteomicsDB; 48292; -. [O14908-1]
DR   Antibodypedia; 13703; 297 antibodies from 34 providers.
DR   DNASU; 10755; -.
DR   Ensembl; ENST00000345425.6; ENSP00000340698.1; ENSG00000123159.16. [O14908-1]
DR   Ensembl; ENST00000393028.5; ENSP00000376748.1; ENSG00000123159.16. [O14908-2]
DR   Ensembl; ENST00000393033.9; ENSP00000376753.3; ENSG00000123159.16. [O14908-1]
DR   Ensembl; ENST00000586027.5; ENSP00000466747.1; ENSG00000123159.16. [O14908-1]
DR   Ensembl; ENST00000591349.5; ENSP00000467077.1; ENSG00000123159.16. [O14908-2]
DR   GeneID; 10755; -.
DR   KEGG; hsa:10755; -.
DR   MANE-Select; ENST00000393033.9; ENSP00000376753.3; NM_005716.4; NP_005707.1.
DR   UCSC; uc002myt.5; human. [O14908-1]
DR   CTD; 10755; -.
DR   DisGeNET; 10755; -.
DR   GeneCards; GIPC1; -.
DR   HGNC; HGNC:1226; GIPC1.
DR   HPA; ENSG00000123159; Tissue enhanced (esophagus).
DR   MalaCards; GIPC1; -.
DR   MIM; 605072; gene.
DR   MIM; 618940; phenotype.
DR   neXtProt; NX_O14908; -.
DR   OpenTargets; ENSG00000123159; -.
DR   Orphanet; 98897; Oculopharyngodistal myopathy.
DR   PharmGKB; PA34371; -.
DR   VEuPathDB; HostDB:ENSG00000123159; -.
DR   eggNOG; KOG3938; Eukaryota.
DR   GeneTree; ENSGT00390000003420; -.
DR   HOGENOM; CLU_044527_1_0_1; -.
DR   InParanoid; O14908; -.
DR   OMA; QIEPQFD; -.
DR   PhylomeDB; O14908; -.
DR   TreeFam; TF313878; -.
DR   PathwayCommons; O14908; -.
DR   SignaLink; O14908; -.
DR   BioGRID-ORCS; 10755; 15 hits in 1077 CRISPR screens.
DR   ChiTaRS; GIPC1; human.
DR   GeneWiki; GIPC1; -.
DR   GenomeRNAi; 10755; -.
DR   Pharos; O14908; Tbio.
DR   PRO; PR:O14908; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; O14908; protein.
DR   Bgee; ENSG00000123159; Expressed in lower esophagus mucosa and 209 other tissues.
DR   ExpressionAtlas; O14908; baseline and differential.
DR   Genevisible; O14908; HS.
DR   GO; GO:0005938; C:cell cortex; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:BHF-UCL.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0043198; C:dendritic shaft; ISS:BHF-UCL.
DR   GO; GO:0043197; C:dendritic spine; ISS:BHF-UCL.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; IEA:Ensembl.
DR   GO; GO:0008021; C:synaptic vesicle; ISS:BHF-UCL.
DR   GO; GO:0012506; C:vesicle membrane; ISS:BHF-UCL.
DR   GO; GO:0003779; F:actin binding; ISS:BHF-UCL.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; ISS:BHF-UCL.
DR   GO; GO:0017022; F:myosin binding; ISS:BHF-UCL.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:UniProtKB.
DR   GO; GO:0098761; P:cellular response to interleukin-7; IEA:Ensembl.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISS:BHF-UCL.
DR   GO; GO:0043542; P:endothelial cell migration; ISS:BHF-UCL.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; NAS:UniProtKB.
DR   GO; GO:0014047; P:glutamate secretion; ISS:BHF-UCL.
DR   GO; GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; ISS:BHF-UCL.
DR   GO; GO:0032467; P:positive regulation of cytokinesis; IMP:UniProtKB.
DR   GO; GO:0048023; P:positive regulation of melanin biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0006605; P:protein targeting; ISS:BHF-UCL.
DR   GO; GO:0031647; P:regulation of protein stability; ISS:BHF-UCL.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; ISS:BHF-UCL.
DR   GO; GO:2000300; P:regulation of synaptic vesicle exocytosis; IEA:Ensembl.
DR   Gene3D; 2.30.42.10; -; 1.
DR   InterPro; IPR017379; GIPC1/2/3.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   PANTHER; PTHR12259; PTHR12259; 1.
DR   Pfam; PF00595; PDZ; 1.
DR   PIRSF; PIRSF038083; UCP038083_GIPC; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SUPFAM; SSF50156; SSF50156; 1.
DR   PROSITE; PS50106; PDZ; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Congenital muscular dystrophy; Cytoplasm;
KW   Dystroglycanopathy; Membrane; Phosphoprotein; Reference proteome.
FT   CHAIN           1..333
FT                   /note="PDZ domain-containing protein GIPC1"
FT                   /id="PRO_0000087492"
FT   DOMAIN          133..213
FT                   /note="PDZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   REGION          1..54
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          223..244
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         68
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         222
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         225
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         232
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         242
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         247
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..97
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_044296"
SQ   SEQUENCE   333 AA;  36049 MW;  AA980A4B907E3FD9 CRC64;
     MPLGLGRRKK APPLVENEEA EPGRGGLGVG EPGPLGGGGS GGPQMGLPPP PPALRPRLVF
     HTQLAHGSPT GRIEGFTNVK ELYGKIAEAF RLPTAEVMFC TLNTHKVDMD KLLGGQIGLE
     DFIFAHVKGQ RKEVEVFKSE DALGLTITDN GAGYAFIKRI KEGSVIDHIH LISVGDMIEA
     INGQSLLGCR HYEVARLLKE LPRGRTFTLK LTEPRKAFDM ISQRSAGGRP GSGPQLGTGR
     GTLRLRSRGP ATVEDLPSAF EEKAIEKVDD LLESYMGIRD TELAATMVEL GKDKRNPDEL
     AEALDERLGD FAFPDEFVFD VWGAIGDAKV GRY
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025